Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sladek

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Expert Opinion on Therapeutic Targets|September 23, 2003
Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areasFrances M Sladek
Cell Cycle (Georgetown, Tex.)|August 17, 2012
The yin and yang of proliferation and differentiation: cyclin D1 inhibits differentiation factors ChREBP and HNF4αFrances M Sladek
Molecular and Cellular Endocrinology|July 10, 2010
What are nuclear receptor ligands?Frances M Sladek
Receptor|January 1, 1993
Orphan receptor HNF-4 and liver-specific gene expressionF M Sladek
Receptor|January 1, 1994
Orphan receptor HNF-4 and liver-specific gene expressionF M Sladek
The Australian Nurses' Journal. Royal Australian Nursing Federation|February 1, 1991
Ante-natal HIV testingW Harvey, M Sladek
Health Information and Libraries Journal|December 17, 2008
Applying evidence in the real world: a case study in library and information practiceRuth M Sladek, Jennifer Tieman
The Journal of Biological Chemistry|January 10, 1997
The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor alphaG Jiang, F M Sladek
American Journal of Obstetrics and Gynecology|December 1, 1996
Nitric oxide synthase activity in the gravid rat uterus decreases a day before the onset of parturitionS M Sladek, J M Roberts
Biochimica Et Biophysica Acta|October 5, 1971
The subcellular distribution of short-chain fatty acyl-CoA synthetase activity in rat tissuesC Barth, M Sladek, K Decker
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Expert Opinion on Therapeutic Targets|September 23, 2003
Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areasFrances M Sladek
Cell Cycle (Georgetown, Tex.)|August 17, 2012
The yin and yang of proliferation and differentiation: cyclin D1 inhibits differentiation factors ChREBP and HNF4αFrances M Sladek
Molecular and Cellular Endocrinology|July 10, 2010
What are nuclear receptor ligands?Frances M Sladek
Receptor|January 1, 1993
Orphan receptor HNF-4 and liver-specific gene expressionF M Sladek
Receptor|January 1, 1994
Orphan receptor HNF-4 and liver-specific gene expressionF M Sladek
The Australian Nurses' Journal. Royal Australian Nursing Federation|February 1, 1991
Ante-natal HIV testingW Harvey, M Sladek
Health Information and Libraries Journal|December 17, 2008
Applying evidence in the real world: a case study in library and information practiceRuth M Sladek, Jennifer Tieman
The Journal of Biological Chemistry|January 10, 1997
The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor alphaG Jiang, F M Sladek
American Journal of Obstetrics and Gynecology|December 1, 1996
Nitric oxide synthase activity in the gravid rat uterus decreases a day before the onset of parturitionS M Sladek, J M Roberts
Biochimica Et Biophysica Acta|October 5, 1971
The subcellular distribution of short-chain fatty acyl-CoA synthetase activity in rat tissuesC Barth, M Sladek, K Decker
Pageof 12